Moreover, it has been recently reported that most circulating tumor cells (CTC) in the blood of metastatic bladder cancer patients present a highly undifferentiated and more aggressive basal phenotype, while overexpressing the STn antigen (221). This evidence concerns the gene EEF1A2 and urinary bladder cancer.